Therefore, we made use of breast cancer 1/2 (BRCA1/2) and p53-deficient mouse mammary tumor organoids as a formaldehyde-sensitive and clinically relevant model (Fig. 2E) (12). This evidence concerns the gene TP53 and breast cancer.